Monitoring of Serum Nitric oxide in Patients with Acute Leukemia

Author(s):
Mohammad Ali GhaffariMohammad Ali Ghaffari1,*, Manizheh Kadkhodaei-ElyaderaniManizheh Kadkhodaei-Elyaderani2, Mohammad Reza SaffariMohammad Reza Saffari3, Mohammad PedramMohammad Pedram4
1Department of Clinical Biochemistry, School of Medicine, Jundishapur University of Medical Sciences, Ahwaz, Iran
2Deptartment of Clinical Biochemistry, School of Medicine, Jundishapur University of Medical Sciences, Ahwaz, Iran
3Department of Clinical Biochemistry and Nutrition, School of Medicine, Hamedan University of Medical Sciences and Health Services, Hamadan, Iran
4Deptartment of Pediatric Hematology and Oncology, Shafa Hospital, Jundishapur University of Medical Sciences, Ahwaz, Iran
*Corresponding Author: Department of Clinical Biochemistry, School of Medicine, Jundishapur University of Medical Sciences, Ahwaz, Iran. Email:[email protected]

IJ Pharmaceutical Research:Vol. 4, issue 4; 233-237
Published online:Nov 20, 2010
Article type:Research Article
Received:Dec 20, 2004
Accepted:Oct 20, 2005
How to Cite:Ghaffari MA, Kadkhodaei-Elyaderani M, Saffari MR, Pedram M. Monitoring of Serum Nitric oxide in Patients with Acute Leukemia. Iran J Pharm Res. 2022;4(4):e128250. doi: https://doi.org/10.22037/ijpr.2010.642

Abstract

Nitric oxide (NO) is a molecule required for many physiological functions, produced from L-arginine by NO synthases (NOS). It is a free radical, producing many reactive intermediates that account for its bioactivity. Sustained induction of the inducible form of NOS (iNOS) in chronic inflammation may be mutagenic, through NO-mediated DNA damage or hindrance to DNA repair, and thus potentially carcinogenic. Due to the short half-life of NO, usually its end products (nitrate or nitrite) are measured as an index of NO production. There is evidence that expression of iNOS in tumor cells, including acute myeloid leukemia and chronic lymphocytic leukemia increased. In this study, the levels of nitrate and nitrite (nitric oxide products) in the serum of patients with acute leukemia were determined.

 

 

The serum levels of these compounds were measured in 40 acute leukemia patients. The results of serum nitrite and nitrate of patients were compared with corresponding values obtained in 40 healthy volunteers.

 

 

These results indicate that patients with acute leukemia had a significant increase in the serum level of nitrite and nitrate.

 

 

Copyright

© 2022, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Jun
2008

Serum nitric oxide metabolite levels in general healthy population: relation to sex and age

Asghar Ghasemi,
Saleh ZahediAsl,
Yadollah Mehrabi,
navid Saadat,
Fereydon Azizi

Ghasemi A, ZahediAsl S, Mehrabi Y, Saadat N, Azizi F. Serum nitric oxide metabolite levels in general healthy population: relation to sex and age. J Inflamm Dis. 2024;12(1):e155371. doi:

26
Sep
2015

Nitrate/L-arginine Therapy and Nitric Oxide Levels in the Stomach and Liver of Rats

Fatemeh Mehrazin,
Asghar Ghasemi,
Saleh Zahediasl

Mehrazin F, Ghasemi A, Zahediasl S. Nitrate/L-arginine Therapy and Nitric Oxide Levels in the Stomach and Liver of Rats. Zahedan J Res Med Sci. 2015;17(9):e1056. doi: https://doi.org/10.17795/zjrms-1056

14
Oct
2018
The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study

The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study

Zahra Bahadoran,
Parvin Mirmiran,
Sajad Jeddi,
Amir Abbas Momenan,
Fereidoun Azizi,
Asghar Ghasemi

Bahadoran Z, Mirmiran P, Jeddi S, Momenan AA, Azizi F, et al. The Nitrate-Nitrite-Nitric Oxide Pathway: Findings from 20 Years of the Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2018;16(4 (Suppl)):e84775. doi: https://doi.org/10.5812/ijem.84775

28
Oct
2017

Elevated Serum 8-Hydroxy-2’-Deoxyguanosine, Nitrite, and Nitrate in Patients with Stage I Multiple Myeloma

Mohammad-Hassan Khadem-Ansari,
Samira Nozari,
Mojtaba Asoudeh,
Yousef Rasmi,
Yousef Faridvand

Khadem-Ansari M, Nozari S, Asoudeh M, Rasmi Y, Faridvand Y. Elevated Serum 8-Hydroxy-2’-Deoxyguanosine, Nitrite, and Nitrate in Patients with Stage I Multiple Myeloma. Int J Cancer Manag. 2017;10(10):e8493. doi: https://doi.org/10.5812/ijcm.8493

13
Jun
2016

Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects

Bayazid Ghaderi,
Sabrieh Amini,
Farzad Maroofi,
Chiya Jalali,
Mitra Javanmardi,
Daem Roshani
,et al.

Ghaderi B, Amini S, Maroofi F, Jalali C, Javanmardi M, et al. Adenosine Deaminase Activity in Chronic Lymphocytic Leukemia and Healthy Subjects. Int J Cancer Manag. 2016;9(3):e5069. doi: https://doi.org/10.17795/ijcp-5069

Download PDF78.10 KB

Crossmark

Crossmark

Checking

Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles